Executive Change: GeneDx (Nasdaq: WGS) Appoints Mark Gardner as President
Stamford, CT – GeneDx has announced the appointment of Mark Gardner as President. About GeneDx: We see a world where every genetic condition is understood, and every patient receives the care they need to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity, the worlds largest rare disease genomic dataset. This unparalleled foundation powers GeneDxs ExomeDx and GenomeDx tests ranked #1 by expert geneticists and granted FDA Breakthrough Device Designation enabling clinicians to deliver precise, fast, and actionable diagnoses. With over 25 years of innovation, more than 4,800 genetic diseases diagnosed, and over 1,000 scientific publications, were building the genomic intelligence network thats shaping the future of precision medicine: for patients, providers, and partners alike.
For more information visit: https://www.genedx.com/
GeneDx
333 Ludlow Street 8th Floor
Stamford, CT 6902
Phone: 888-729-1206
LinkedIn: https://www.linkedin.com/company/genedx/
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved
